Can you show me how to find the value of the firm using these financial statements?

ent Consolidated Balance Sheets - USD ($) Jun 30, 2020 Jun 30, 2019 $ in Millions Current assets: Cash and equivalents S 2.771 $ 2531 Trade receivables, net 8.254 8,448 Inventories, net 13,198 12,822 Prepaid expenses and other 1,707 1946 Total current assets 25,940 25,747 Property and equipment, net 2.366 2,356 Goodwill and other intangih niet 11,275 11.808 Other assets 1.185 1.052 Total assets 40.766 40,963 Current liabilities: Accounts payable 21.374 21,535 Current portion of long-ten Sanons and other short-term borrowings 10 452 Other accrued liabilities 2.231 2. 122 Total current liabilities 23,615 24,109 Long-term obligations, less current portion 6.765 7.579 Deferred income taxes and other liabilities 8 594 2.945 Preferred shares, without par value: Authorized thousand shares Issued 0 none Common shares, without par value: Authorized--755 million shares. Issued 327 million shares at June 30, 2020 and 2789 2,763 2019, respectively Retained earnings 1.170 5.434 Common shares in treasury, at cost 34 million shares and 28 million shares at (2,066) (1.790) June 30, 2020 and 2019, respectively Accumulated other comprehensive loss (104) Total Cardinal Health Inc shareholders 1.789 6,328 equity Noncontrolling interests 3 2 Total shareholders' equity 1.792 6,330 Total abilities and shareho dors equity $ 40 756 $ 40.963 0 nt 12 Months Ended Jun. 30, 2020 Jun 30, 2019 Jun. 30, 2018 S (3.693) S 1,365 S 259 3 18 Consolidated Statements of Comprehensive Income - USD ($) $ in Millions Statement of Comprehensive Income [Abstract] Net earnings Other comprehensive income (loss): Foreign currency translation adjustments and other Amounts reclassified to earnings Net unrealized gain/(loss) on derivative instruments, net of tax Total other comprehensive income!(loss). net of tax Total comprehensive income/(loss) Net Income (Loss) Attributable to Noncontrolling Interest Total comprehensive income attributable to Cardinal Health, Inc. 58 0 0 (23) (28) (5) (2) (25) 13 33 (3.718) 1.378 292 3 2 3 S (3.721) S 1,376 S 289 hent Consolidated Statements of Cash 12 Months Ended Flows - USD ($) Sin Millions Jun. 30. 2020 Jun 30, 2019 Jun. 30, 2018 Cash flows from operating activities: Net earnings S (3,693) $ 1,365 $ 259 Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities: Depreciation and amortization 913 1,000 1,032 Loss on Sale of Investments 0 3 6 Gain on Sale of Investments (579) 0 0 impairments and (gain loss on disposal 7 of assets, net (488) 1,417 Loss on early extinguishment of debt 16 0 2 Share-based compensation 90 82 85 Provision for (benefit from deferred income taxes (961) (83) (1.012 Provision for bad debts 106 88 74 Change in fair value of contingent 0 0 (2) consideration obligation Change in operating assets and liabilities, net of effects from acquisitions and divestitures: Decreasel increase in trade receivables 82 (751) (871) Increase in inventories (409) (551) (1.211) Increase (decrease in accounts payable (162) 1.864 2.574 Other accrued liabilities and operating 6.550 193 415 items, net Net cash provided by operating activities 1.950 2.722 2.768 Cash flows from investing activities: Acquisition of subsidiaries net of cash acquired 0 (82) (6.142) Additions to property and equipment (375) (328) (384) Purchase of other investments (20) (18) (9) Proceeds from sale of investments and 886 3 65 available for sale Securities Proceeds for givestitures, net of cash said and disposa of property and 763 862 equipment Net cash provided by used in investing 493 338 (5,603 CA Cast flows from inancing activities: ments 82 (409) (162) (751) (551) 1,854 (871) (1.211) 2,574 6.550 193 415 1,960 2,722 2,768 0 (82) (6,142) (375) (20) (328) (18) (384) (9) 886 3 65 2 763 862 493 338 (5,608) 0 (35) (2) 0 (50) Decrease increase) in trade receivables Increase in inventories Increase (decrease) in accounts payable Other accrued liabilities and operating items, net Net cash provided by operating activities Cash flows from investing activities: Acquisition of subsidiaries, net of cash acquired Additions to property and equipment Purchase of other investments Proceeds from sale of investments and available for sale securities Proceeds from divestitures, net of cash sold, and disposal of property and equipment Net cash provided by used in) investing activities Cash flows from financing activities: Payment of contingent consideration obligation Net change in short-term borrowings Payments to Acquire Businesses and interest in Affiliates Reduction of long-term obligations Proceeds from interest rate swap terminations Proceeds from long-term obligations.net of issuance costs Net tax proceeds withholding) from share-based compensation Dividends on common shares Purchase of treasury shares Net cash used in financing activities Effect of exchange rates changes on cash and equivalents Cash reciassified to assets held for sale Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease including Exchange Rate Effect Cash and equivalents at beginning of period Cash and equivalents at end of period Supplemental Information: Cash payments for interest Cash payments for income taxes 0 0 106 (1.399) (1,102) (954) 112 0 0 0 0 3 (14) (3) 8 (569) (350) (2 200) (577) (600) 12.293) (581) (550) (2.276) (13) 1 4 0 0 (4) 240 768 15.116) 2.531 1.763 6879 2.771 1.763 2.531 1 285 $ 311 226 $ 358 320 $ 425 ent Consolidated Balance Sheets - USD ($) Jun 30, 2020 Jun 30, 2019 $ in Millions Current assets: Cash and equivalents S 2.771 $ 2531 Trade receivables, net 8.254 8,448 Inventories, net 13,198 12,822 Prepaid expenses and other 1,707 1946 Total current assets 25,940 25,747 Property and equipment, net 2.366 2,356 Goodwill and other intangih niet 11,275 11.808 Other assets 1.185 1.052 Total assets 40.766 40,963 Current liabilities: Accounts payable 21.374 21,535 Current portion of long-ten Sanons and other short-term borrowings 10 452 Other accrued liabilities 2.231 2. 122 Total current liabilities 23,615 24,109 Long-term obligations, less current portion 6.765 7.579 Deferred income taxes and other liabilities 8 594 2.945 Preferred shares, without par value: Authorized thousand shares Issued 0 none Common shares, without par value: Authorized--755 million shares. Issued 327 million shares at June 30, 2020 and 2789 2,763 2019, respectively Retained earnings 1.170 5.434 Common shares in treasury, at cost 34 million shares and 28 million shares at (2,066) (1.790) June 30, 2020 and 2019, respectively Accumulated other comprehensive loss (104) Total Cardinal Health Inc shareholders 1.789 6,328 equity Noncontrolling interests 3 2 Total shareholders' equity 1.792 6,330 Total abilities and shareho dors equity $ 40 756 $ 40.963 0 nt 12 Months Ended Jun. 30, 2020 Jun 30, 2019 Jun. 30, 2018 S (3.693) S 1,365 S 259 3 18 Consolidated Statements of Comprehensive Income - USD ($) $ in Millions Statement of Comprehensive Income [Abstract] Net earnings Other comprehensive income (loss): Foreign currency translation adjustments and other Amounts reclassified to earnings Net unrealized gain/(loss) on derivative instruments, net of tax Total other comprehensive income!(loss). net of tax Total comprehensive income/(loss) Net Income (Loss) Attributable to Noncontrolling Interest Total comprehensive income attributable to Cardinal Health, Inc. 58 0 0 (23) (28) (5) (2) (25) 13 33 (3.718) 1.378 292 3 2 3 S (3.721) S 1,376 S 289 hent Consolidated Statements of Cash 12 Months Ended Flows - USD ($) Sin Millions Jun. 30. 2020 Jun 30, 2019 Jun. 30, 2018 Cash flows from operating activities: Net earnings S (3,693) $ 1,365 $ 259 Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities: Depreciation and amortization 913 1,000 1,032 Loss on Sale of Investments 0 3 6 Gain on Sale of Investments (579) 0 0 impairments and (gain loss on disposal 7 of assets, net (488) 1,417 Loss on early extinguishment of debt 16 0 2 Share-based compensation 90 82 85 Provision for (benefit from deferred income taxes (961) (83) (1.012 Provision for bad debts 106 88 74 Change in fair value of contingent 0 0 (2) consideration obligation Change in operating assets and liabilities, net of effects from acquisitions and divestitures: Decreasel increase in trade receivables 82 (751) (871) Increase in inventories (409) (551) (1.211) Increase (decrease in accounts payable (162) 1.864 2.574 Other accrued liabilities and operating 6.550 193 415 items, net Net cash provided by operating activities 1.950 2.722 2.768 Cash flows from investing activities: Acquisition of subsidiaries net of cash acquired 0 (82) (6.142) Additions to property and equipment (375) (328) (384) Purchase of other investments (20) (18) (9) Proceeds from sale of investments and 886 3 65 available for sale Securities Proceeds for givestitures, net of cash said and disposa of property and 763 862 equipment Net cash provided by used in investing 493 338 (5,603 CA Cast flows from inancing activities: ments 82 (409) (162) (751) (551) 1,854 (871) (1.211) 2,574 6.550 193 415 1,960 2,722 2,768 0 (82) (6,142) (375) (20) (328) (18) (384) (9) 886 3 65 2 763 862 493 338 (5,608) 0 (35) (2) 0 (50) Decrease increase) in trade receivables Increase in inventories Increase (decrease) in accounts payable Other accrued liabilities and operating items, net Net cash provided by operating activities Cash flows from investing activities: Acquisition of subsidiaries, net of cash acquired Additions to property and equipment Purchase of other investments Proceeds from sale of investments and available for sale securities Proceeds from divestitures, net of cash sold, and disposal of property and equipment Net cash provided by used in) investing activities Cash flows from financing activities: Payment of contingent consideration obligation Net change in short-term borrowings Payments to Acquire Businesses and interest in Affiliates Reduction of long-term obligations Proceeds from interest rate swap terminations Proceeds from long-term obligations.net of issuance costs Net tax proceeds withholding) from share-based compensation Dividends on common shares Purchase of treasury shares Net cash used in financing activities Effect of exchange rates changes on cash and equivalents Cash reciassified to assets held for sale Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease including Exchange Rate Effect Cash and equivalents at beginning of period Cash and equivalents at end of period Supplemental Information: Cash payments for interest Cash payments for income taxes 0 0 106 (1.399) (1,102) (954) 112 0 0 0 0 3 (14) (3) 8 (569) (350) (2 200) (577) (600) 12.293) (581) (550) (2.276) (13) 1 4 0 0 (4) 240 768 15.116) 2.531 1.763 6879 2.771 1.763 2.531 1 285 $ 311 226 $ 358 320 $ 425